Samsung Biologics to provide end-to-end mRNA vaccine manufacturing

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, May 31, 2021 at 7:32 PM.

  1. #1 cafead, May 31, 2021 at 7:32 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,990
    Likes Received:
    3
    via Samsung Biologics will add mRNA vaccine drug substance production capability to its facility in South Korea, aiming to provide end-to-end mRNA vaccine manufacturing services.

    article source
     
    Quote

Reply to Thread